Eucrisa (Anacor Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Eucrisa drug offered from Anacor Pharmaceuticals, Inc.. This Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Anacor Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: crisaborole
SUBSTANCE NAME: CRISABOROLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-01-30
END MARKETING DATE: 0000-00-00


Eucrisa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEucrisa from Anacor Pharmaceuticals, Inc.
LABELER NAME: Anacor Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/g)
START MARKETING DATE: 2017-01-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55724-211_1a822edc-ab94-4351-8dc9-314d40ee6e83
PRODUCT NDC: 55724-211
APPLICATION NUMBER: NDA207695

Other CRISABOROLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Anacor Pharmaceuticals, Inc.Eucrisa